https://www.selleckchem.com/pr....oducts/mpp-dihydroch
Correlation of SMD using SliceOMatic whole muscle measurements with PACS psoas muscle was 0.76 (p .0001) and with PACS erector spinae muscle 0.91 (p .0001). Using PACS psoas muscle, myosteatosis was associated with any adverse event [RR 1.66, CI 1.22-2.26 (p .0001)], dose reduction [RR 1.63, CI 1.01-2.65 (p = .05)], and early treatment discontinuation [RR 2.14, CI 1.10-4.14 (p = 0.03)]. Using PACS erector spinae muscle, myosteatosis was associated any adverse event [RR 1.59, CI 1.11-2.27 (p = 0.01)] and dose r
Like
Comment
Share
